Antipsychotic Use in Nursing Homes: Problem and Alternatives (References)

Alzheimer’s Association (2006). Dementia care practice recommendations for assisted living residences and nursing homes. J. Tilly, & P. Reed, (Eds). Retrieved from

Bakerjian, D. (2012). GAPNA participates in Centers for Medicare and Medicaid Services (CMS) initiative to reduce antipsychotic use for nursing home residents with dementia. Geriatric Nursing, 33(4), 319-320.

Centers for Medicaid and Medicare Services (2012). CMS announces partnership to improve dementia care in nursing homes: Government partnering with providers, caregivers, patients to ensure appropriate use of antipsychotic medications. Press release. Retrieved from:

Cerijeira, J., Lagarto, L., Mukaetova-Ludenska, E. (2012). Behavioral and psychological symptoms of dementia. Frontiers in Neurology, 3(73); 1-21. Retrieved from

Constantine, G., Lyketsos, M., Lopez, O., Jones, B., Fitzpatrick, A., Breitner, J.,& DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. Journal of the American Medical Association, 288(12): 1475-1483.

Dettmore, D., Kolanowski, A., & Boustani, M. (2009). Aggression in persons with dementia: Use of nursing theory to guide clinical practice. Geriatric Nursing, 30(1), 8-17.

Food and Drug Administration (2005). Deaths with antipsychotics in elderly patients with behavioral disturbances. FDA public health advisory. Retrieved from:

Food and Drug Administration (2008). Antipsychotics: Conventional and atypical. Retrieved from: Information/SafetyAlertsfor humanMedicalProducts/ucm110212.htmHartford

Hartford Institute of Geriatric Nursing (2008). Dementia. In K. Fletcher, E. Capezuti, D. Zwicker, M. Mezey, & T. Fulmer, (Eds.). Evidence based geriatric nursing protocols for best practice. (3rd ed., pp. 83-109) New York: Springer Publishing Co.

Jeste, D.V., Blazer, D., Casey, D., Meeks, T., Salzman, C., Schneider, L., Tariot, P.,& Yaffe, K. (2008). ACNP white paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology, 33(5), 957-970.

Lester, P. (2011). Antipsychotic drug use since the FDA black box warning: Survey of nursing home policies. American Medical Directors Association, 10; 573-577.

Okura, T., Plassman, B. L., Steffens, D. C., Llewellyn, D. J., Potter, G. G.,& Langa, K. M. (2010). ). Neuropsychiatric symptoms and the risk of institutionalization and death: The aging, demographics and memory study. Journal of Geriatric Society, 59(3): 473-481.

Plassman, B., Langa, K., Fisher, G., Herringa, S., Weir, D., Ofstedal, M. et al., (2007).Presence of dementia in the United States: The aging demographics and memory study. Neuroepidemiology, 29(1-2): 125-132.

Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association 294(15), 1934-43.

Testad, I., Aasland, A. M. & Aarsland, D. (2007). Prevalence and correlates of disruptive behavior in patients in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22(9), 843-849.

U.S. Census Bureau. (2010). The next four decades: the older population in the United States: 2010 to 2050. Washington, D.C: U.S. Department of Commerce Retrieved from